Characterizing the novel protein p33MONOX

Molecular and Cellular Biochemistry

Volumn 350, Issue 1-2, 2011, Pages 127-134

  Mishra, Manisha ^a   Inoue, Noriko ^b   Heese, Klaus ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Alzheimer's disease; Apoptosis; Neurodegeneration

Indexed keywords

ACRIFLAVINE; BRCA1 PROTEIN; P33MONOX PROTEIN; PRION PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; BRAIN; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOLOGY; CYTOPLASM; DOWN REGULATION; HEMODYNAMICS; HIPPOCAMPUS; HYBRIDIZATION; IMMUNOPRECIPITATION; MOUSE; NERVE CELL; NONHUMAN; PROTEIN INTERACTION; PROTEIN MOTIF; PYRAMIDAL NERVE CELL;

AMINO ACID SEQUENCE; ANIMALS; AXONS; CELLS, CULTURED; CLONING, MOLECULAR; HUMANS; MICE; MICE, INBRED C57BL; MIXED FUNCTION OXYGENASES; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; PC12 CELLS; PYRAMIDAL CELLS; RATS; SEQUENCE ANALYSIS, PROTEIN; TRANSFECTION;

EID: 79953701025     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0690-4     Document Type: Article

References (52)

1. Welsh KA, Butters N, Hughes JP, Mohs RC, Heyman A (1992) Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol 49:448-452
2. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580
3. Heese K, Akatsu H (2006) Alzheimer's disease - an interactive perspective. Curr Alzheimer Res 3:109-121
4. Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430:631-639
5. Selkoe DJ, Schenk D (2003) Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 43:545-584 (Pubitemid 37372653)
6. Butterfield DA (2002) Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res 36:1307-1313
7. Butterfield DA, Castegna A, Lauderback CM, Drake J (2002) Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23:655-664 (Pubitemid 35217687)
8. Pappolla MA, Chyan YJ, Omar RA, Hsiao K, Perry G, Smith MA, Bozner P (1998) Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am J Pathol 152:871-877 (Pubitemid 28173347)
9. Yokota T, Mishra M, Akatsu H, Tani Y, Miyauchi T, Yamamoto T, Kosaka K, Nagai Y, Sawada T, Heese K (2006) Brain site-specific gene expression analysis in Alzheimer's disease patients. Eur J Clin Invest 36:820-830 (Pubitemid 44569971)
10. Heese K, Yamada T, Akatsu H, Yamamoto T, Kosaka K, Nagai Y, Sawada T (2004) Characterizing the new transcription regulator protein p60TRP. J Cell Biochem 91:1030-1042
11. Nehar S, Mishra M, Heese K (2009) Identification and characterisation of the novel amyloid-beta peptide-induced protein p17. FEBS Lett 583:3247-3253
12. Massey V (1995) Introduction: flavoprotein structure and mechanism. FASEB J 9:473-475
13. Yeung CK, Lang DH, Thummel KE, Rettie AE (2000) Immunoquantitation of FMO1 in human liver, kidney, and intestine. Drug Metab Dispos 28:1107-1111 (Pubitemid 30660367)
14. Ziegler DM (1990) Flavin-containing monooxygenases: enzymes adapted for multisubstrate specificity. Trends Pharmacol Sci 11:321-324
15. Massey V (1994) Activation of molecular oxygen by flavins and flavoproteins. J Biol Chem 269:22459-22462
16. Lee MS, Kao SC, Lemere CA, Xia W, Tseng HC, Zhou Y, Neve R, Ahlijanian MK, Tsai LH (2003) APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol 163:83-95 (Pubitemid 37271436)
17. Ito T, Deng X, Carr B, May WS (1997) Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem272:11671-11673 (Pubitemid 27202724)
18. Deng X, Ito T, Carr B, Mumby M, May WS Jr (1998) Reversible phosphorylation of Bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2A. J Biol Chem 273:34157-34163 (Pubitemid 29008888)
19. Deng X, Gao F, Flagg T, May WS Jr (2004) Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions. Proc Natl Acad Sci USA 101:153-158 (Pubitemid 38084219)
20. Yamamoto K, Ichijo H, Korsmeyer SJ (1999) BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 19:8469-8478
21. Chang BS, Minn AJ, Muchmore SW, Fesik SW, Thompson CB (1997) Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. EMBO J 16:968-977 (Pubitemid 27113176)
22. Liu XA, Liao K, Liu R, Wang HH, Zhang Y, Zhang Q, Wang Q, Li HL, Tian Q, Wang JZ (2010) Tau dephosphorylation potentiates apoptosis by mechanisms involving a failed dephosphorylation/activation of Bcl-2. J Alzheimer's Dis 19:953-962
23. Kholodenko BN (2007) Untangling the signalling wires. Nat Cell Biol 9:247-249
24. McChesney PA, Aiyar SE, Lee OJ, Zaika A, Moskaluk C, Li R, El-Rifai W (2006) Cofactor of BRCA1: a novel transcription factor regulator in upper gastrointestinal adenocarcinomas. Cancer Res 66:1346-1353 (Pubitemid 43259913)
25. Kramer PR, Wray S (2001) Nasal embryonic LHRH factor (NELF) expression within the CNS and PNS of the rodent. Brain Res Gene Expr Patterns 1:23-26 (Pubitemid 33634191)
26. Kramer PR, Wray S (2000) Novel gene expressed in nasal region influences outgrowth of olfactory axons and migration of luteinizing hormone-releasing hormone (LHRH) neurons. Genes Dev 14:1824-1834 (Pubitemid 30603000)
27. Sun J, Blair AL, Aiyar SE, Li R (2007) Cofactor of BRCA1 modulates androgen-dependent transcription and alternative splicing. J Steroid Biochem Mol Biol 107:131-139 (Pubitemid 47380383)
28. Narita T, Yamaguchi Y, Yano K, Sugimoto S, Chanarat S, Wada T, Kim DK, Hasegawa J, Omori M, Inukai N, Endoh M, Yamada T, Handa H (2003) Human transcription elongation factor NELF: identification of novel subunits and reconstitution of the functionally active complex. Mol Cell Biol 23:1863-1873 (Pubitemid 36278801)
29. Suzuki S, Kanno M, Fujiwara T, Sugiyama H, Yokoyama A, Takahashi H, Tanaka J (2006) Molecular cloning and characterization of Nop25, a novel nucleolar RNA binding protein, highly conserved in vertebrate species. Exp Cell Res 312:1031-1041
30. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, Stroedicke M, Zenkner M, Schoenherr A, Koeppen S, Timm J, Mintzlaff S, Abraham C, Bock N, Kietzmann S, Goedde A, Toksoz E, Droege A, Krobitsch S, Korn B, Birchmeier W, Lehrach H, Wanker EE (2005) A human protein-protein interaction network: a resource for annotating the proteome. Cell 122:957-968 (Pubitemid 41345212)
31. Juanes ME, Elvira G, Garcia-Grande A, Calero M, Gasset M (2009) Biosynthesis of prion protein nucleocytoplasmic isoforms by alternative initiation of translation. J Biol Chem 284:2787-2794
32. Satoh J, Obayashi S, Misawa T, Sumiyoshi K, Oosumi K, Tabunoki H (2009) Protein microarray analysis identifies human cellular prion protein interactors. Neuropathol Appl Neurobiol 35:16-35
33. Haigh CL, Lewis VA, Vella LJ, Masters CL, Hill AF, Lawson VA, Collins SJ (2009) PrPC-related signal transduction is influenced by copper, membrane integrity and the alpha cleavage site. Cell Res 19:1062-1078
34. Haitina T, Lindblom J, Renstrom T, Fredriksson R (2006) Fourteen novel human members of mitochondrial solute carrier family 25 (SLC25) widely expressed in the central nervous system. Genomics 88:779-790 (Pubitemid 44739199)
35. Miao L, St Clair DK (2009) Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med 47:344-356
36. Lynn S, Huang EJ, Elchuri S, Naeemuddin M, Nishinaka Y, Yodoi J, Ferriero DM, Epstein CJ, Huang TT (2005) Selective neuronal vulnerability and inadequate stress response in superoxide dismutase mutant mice. Free Radic Biol Med 38:817-828 (Pubitemid 40249752)
37. Terman JR, Mao T, Pasterkamp RJ, Yu HH, Kolodkin AL (2002) MICALs, a family of conserved flavoprotein oxidoreductases, function in plexin-mediated axonal repulsion. Cell 109:887-900 (Pubitemid 34786003)
38. Massey V, Palmer G (1966) On the existence of spectrally distinct classes of flavoprotein semiquinones. A new method for the quantitative production of flavoprotein semiquinones. Biochemistry 5:3181-3189
39. Ventura A, Pelicci PG (2002) Semaphorins: green light for redox signaling? Sci STKE 2002: pe44
40. Kamata H, Hirata H (1999) Redox regulation of cellular signalling. Cell Signal 11:1-14 (Pubitemid 28546635)
41. Finkel T (1998) Oxygen radicals and signaling. Curr Opin Cell Biol 10:248-253
42. Meng TC, Fukada T, Tonks NK (2002) Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9:387-399 (Pubitemid 34195563)
43. Juurlink BH, Paterson PG (1998) Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies. J Spinal Cord Med 21:309-334 (Pubitemid 128731776)
44. Lovell MA, Ehmann WD, Butler SM, Markesbery WR (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45:1594-1601
45. Schuessel K, Leutner S, Cairns NJ, Muller WE, Eckert A (2004) Impact of gender on upregulation of antioxidant defence mechanisms inAlzheimer's disease brain. JNeural Transm111:1167-1182 (Pubitemid 39222776)
46. Nunomura A, Chiba S, Lippa CF, Cras P, Kalaria RN, Takeda A, Honda K, Smith MA, Perry G (2004) Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease. Neurobiol Dis 17:108-113 (Pubitemid 39209318)
47. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA (2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21:3017-3023 (Pubitemid 32323483)
48. Behl C (2005) Oxidative stress in Alzheimer's disease: implications for prevention and therapy. Subcell Biochem 38:65-78
49. Reddy PH (2006) Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J Neurochem 96:1-13
50. Premkumar DR, Smith MA, Richey PL, Petersen RB, Castellani R, Kutty RK, Wiggert B, Perry G, Kalaria RN (1995) Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease. J Neurochem 65:1399-1402
51. Schipper HM, Cisse S, Stopa EG (1995) Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol 37:758-768
52. Smith MA, Kutty RK, Richey PL, Yan SD, Stern D, Chader GJ, Wiggert B, Petersen RB, Perry G (1994) Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol 145:42-47 (Pubitemid 24217481)